Cargando…
Drug Development Against Metastatic Cancers
While combinational diagnostic and treatment strategies over the past decades have significantly improved the overall survival of cancer patients, metastatic cancer remains a leading cause of death in developed countries. The lack of successful treatment strategies for the disease is in large part d...
Autores principales: | Wang, Chen, Huang, Sui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
YJBM
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369029/ https://www.ncbi.nlm.nih.gov/pubmed/28356899 |
Ejemplares similares
-
New drug developments in metastatic gastric cancer
por: Tan, Aaron C., et al.
Publicado: (2018) -
Molecularly targeted drugs for metastatic colorectal cancer
por: Cheng, Ying-dong, et al.
Publicado: (2013) -
Oral drugs in the treatment of metastatic colorectal cancer
por: García-Alfonso, Pilar, et al.
Publicado: (2021) -
Predictive biomarkers in precision medicine and drug development against lung cancer
por: Fang, Bingliang, et al.
Publicado: (2015) -
New drugs for the treatment of metastatic colorectal cancer
por: Cherri, Sara, et al.
Publicado: (2021)